Causes, diagnosis and treatment of pharyngitis

Comprehensive Therapy

Volumn 25, Issue 6-7, 1999, Pages 326-329

  Huovinen, Pentti ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFADROXIL; CEFALEXIN; CEPHALOSPORIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN V;

ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; CHLAMYDIA TRACHOMATIS; CORYNEBACTERIUM DIPHTHERIAE; IMMUNOASSAY; MEDICAL DECISION MAKING; MICROBIOLOGICAL EXAMINATION; NEISSERIA GONORRHOEAE; PHARYNGITIS; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS GROUP C; STREPTOCOCCUS GROUP G; STREPTOCOCCUS PYOGENES;

EID: 0032855652     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02944278     Document Type: Article

References (30)

1. Dixon RE. Economic costs of respiratory tract infections in the United States. Am J Med. 1985;78(suppl 6B):45-51.
2. Rautakorpi UM, Lumio J, Huovinen P, et al. Indicationbased use of antimicrobials in Finnish primary health care. Description of a method for data collection and results of its application. Scand J Prim Health Care, in press.
3. Little P, Williamson I, Warner G, et al. Open randomised trial of prescribing strategies in managing sore throat. BMJ. 1997;314:722-727.
4. Huovinen P, Lahtonen R, Ziegler T, et al. Pharyngitis in adults; the presence and co-existence of viruses and bacterial organisms. Ann Intern Med. 1989;110:612-616.
5. Glezen WP, Clyde WA Jr., Senior RJ, et al. Group A streptococci, mycoplasmas, and viruses associated with acute pharyngitis. JAMA. 1967;202:455-460.
6. Putto A. Febrile exudative tonsillitis: viral or streptococcal? Pediatrics. 1987;80:6-12.
7. Huovinen P. Causes, diagnosis, and treatment of pharyngitis. ComprTher. 1990;16:59-65.
8. Smith DS. Current concepts in the management of pharyngitis. Compr Ther. 1996;22:806-809.
9. Carlson P, Renkonen OV, Kontiainen S. Arcanobacterium haemolyticum and streptococcal pharyngitis. Scand J Infect Dis. 1994;26:283-287.
10. Kaplan EL. Clinical guidelines for group A streptococcal throat infections. Lancet. 1997;350:899-900.
11. Seppälä H, Lahtonen R, Ziegler T, et al. Clinical scoring system in the evaluation of adult pharyngitis. Arch Otolaryngol Head Neck Surgery. 1993;119:288-291.
12. Turner JC, Hayden FG, Lobo MC, et al. Epidemiologic evidence for Lancefield group C beta-hemolytic streptococci as a cause of exudative pharyngitis in college students. J Clin Microbiol. 1997;35:1-4.
13. Jansen TL, Janssen M, de Jong AJ. Reactive arthritis associated with group C and group G beta-hemolytic streptococci. J Rheumatol. 1998;26:1126-1130.
14. Cimolai N, Elford RW, Bryan L, et al. Do the beta-hemolytic non-group A streptococci cause pharyngitis? Rev Infect Dis. 1988;10:587-601.
15. Bisno AL, Gerber MA, Gwaltney JM Jr, et al. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Clin Infect Dis. 1997;25:574-583.
16. Gerber MA. Use of antigen detection tests in the diagnosis and management of patients with group A streptococcal pharyngitis. Pediatr Infect Dis J. 1997;12:1187.
17. Webb KH. Does culture confirmation of high-sensitivity rapid streptococcal tests make sense? A medical decision analysis. Pediatrics. 1998;101:2.
18. Gerber MA, Tanz RR, Kabat W, et al. Optical immunoassay test for group A beta-hemolytic streptococcal pharyngitis: an office-based, multicenter investigation. JAMA. 1997;277: 899-903.
19. Steinhoff MC, Khalek MKAE, Khallaf N, et al. Effectiveness of clinical guidelines for the presumptive treatment of streptococcal pharyngitis in Egyptian children. Lancet. 1997;350:918-921.
20. Pichichero ME. Streptococcal pharyngitis: is penicillin still the right choice? Compr Ther. 1996;22:782-787.
21. Horn DL, Zabriskie JB, Austrian R, et al. Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis. 1998;26:1341-1345.
22. Seppälä H, Nissinen A, Järvinen H, et al. Emergence of erythromycin resistance in group A strep-tococci. N Engl J Med. 1992;326:292-297.
23. Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effects of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med. 1997;337:441-446.
24. Seppälä H, Klaukka T Lehtonen R, Nenonen E, Finnish Study Group for Antimicrobial Resistance, Huovinen P. Outpatient use of erythromycin-link to increased erythromycin resistance in group A streptococci. Clin Infect Dis. 1995;21:1378-1385.
25. Roos K, Holm SE, Grahn-Håkansson E, et al. Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled multicentre study. Scand J Infect Dis. 1996;28:459-462.
26. Wise R, Hart T, Cars O, et al. Antimicrobial resistance is a major threat to public health. BMJ. 1998;317:609-610.
27. Huovinen P, Cars O. Control of antimicrobial resistance: time for action. BMJ. 1998;317:613-614.
28. Smith HS, Hughes JP, Hooton TM, et al. Atecedent antimicrobial use increases the risk of uncomplicated cystitis in young women. Clin Infect Dis. 1997;25:63-68.
29. Bisno AL. Acute pharyngitis: etiology and diagnosis. Pediatrics. 1996;97:949-954.
30. Centor RM, Meier FA, Dalton HP. Throat culture and rapid tests for diagnosis of group A streptococcal pharyngitis. Ann Intern Med. 1986;105:892-899.